4-羟基-4-(羟甲基)哌啶-1-甲酸叔丁酯, 99%,tert-Butyl 4-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate
产品编号:西域试剂-WR194153| CAS NO:389889-80-9| MDL NO:MFCD08062514| 分子式:C11H21NO4| 分子量:231.29
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
| 英文名称 | tert-Butyl 4-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate |
|---|---|
| CAS编号 | 389889-80-9 |
| 产品沸点 | 350.9±27.0 °C at 760 mmHg |
| 产品密度 | 1.2±0.1 g/cm3 |
| 产品闪点 | 166.0±23.7 °C |
| 精确质量 | 231.147064 |
| PSA | 70.00000 |
| LogP | 0.00 |
| 蒸气压 | 0.0±1.7 mmHg at 25°C |
| 折射率 | 1.507 |
相关文档
化学品安全说明书(MSDS)
下载MSDS质检证书(COA)
相关产品
| 海关编码 | 2933399090 |
|---|
|
~%
389889-80-9 |
| 文献:Ogino, Yoshio; Kurihara, Hideki; Matsuda, Kenji; Numazawa, Tomoshige; Otake, Norikazu; Noguchi, Kazuhito Patent: US2003/191316 A1, 2003 ; Location in patent: Page/Page column 36 ; |
|
~%
389889-80-9 |
| 文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; Location in patent: Page/Page column 197 ; |
|
~%
389889-80-9 |
| 文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
|
~%
389889-80-9 |
| 文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
|
~%
389889-80-9 |
| 文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
|
~%
389889-80-9 |
| 文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
| 上游产品 7 | |
|---|---|
| 下游产品 0 | |

浙公网安备 33010802013016号